These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9371992)

  • 1. Biology and potential clinical applications of flt3 ligand.
    Lyman SD; Williams DE
    Curr Opin Hematol; 1995 May; 2(3):177-81. PubMed ID: 9371992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of flt3 ligand and receptor.
    Lyman SD
    Int J Hematol; 1995 Aug; 62(2):63-73. PubMed ID: 8590775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.
    Lyman SD; Brasel K; Rousseau AM; Williams DE
    Stem Cells; 1994; 12 Suppl 1():99-107; discussion 108-10. PubMed ID: 7535149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic effects and potential clinical applications of Flt3 ligand.
    Lyman SD
    Curr Opin Hematol; 1998 May; 5(3):192-6. PubMed ID: 9664159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flt3 ligand can promote survival and macrophage development without proliferation in myeloid progenitor cells.
    Nicholls SE; Winter S; Mottram R; Miyan JA; Whetton AD
    Exp Hematol; 1999 Apr; 27(4):663-72. PubMed ID: 10210324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells.
    Lyman SD; James L; Vanden Bos T; de Vries P; Brasel K; Gliniak B; Hollingsworth LT; Picha KS; McKenna HJ; Splett RR
    Cell; 1993 Dec; 75(6):1157-67. PubMed ID: 7505204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of human and murine flt3 ligand genomic loci.
    Lyman SD; Stocking K; Davison B; Fletcher F; Johnson L; Escobar S
    Oncogene; 1995 Sep; 11(6):1165-72. PubMed ID: 7566977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots.
    Savvides SN; Boone T; Andrew Karplus P
    Nat Struct Biol; 2000 Jun; 7(6):486-91. PubMed ID: 10881197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells.
    Hjertson M; Sundström C; Lyman SD; Nilsson K; Nilsson G
    Exp Hematol; 1996 May; 24(6):748-54. PubMed ID: 8635531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities.
    Lyman SD; Jacobsen SE
    Blood; 1998 Feb; 91(4):1101-34. PubMed ID: 9454740
    [No Abstract]   [Full Text] [Related]  

  • 12. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of FLT3 and its ligand in normal hematopoietic progenitor cells.
    Weisel KC; Yildirim S; Schweikle E; Kanz L; Möhle R
    Ann Hematol; 2009 Mar; 88(3):203-11. PubMed ID: 18797870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.
    Stacchini A; Fubini L; Severino A; Sanavio F; Aglietta M; Piacibello W
    Leukemia; 1996 Oct; 10(10):1584-91. PubMed ID: 8847893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors.
    Curti A; Fogli M; Ratta M; Tura S; Lemoli RM
    J Immunol; 2001 Jan; 166(2):848-54. PubMed ID: 11145659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs.
    Hannum C; Culpepper J; Campbell D; McClanahan T; Zurawski S; Bazan JF; Kastelein R; Hudak S; Wagner J; Mattson J
    Nature; 1994 Apr; 368(6472):643-8. PubMed ID: 8145851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities and potential therapeutic uses of steel factor. A new growth factor active on multiple hematopoietic lineages.
    Lyman SD; Williams DE
    Am J Pediatr Hematol Oncol; 1992; 14(1):1-7. PubMed ID: 1372488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells.
    Broxmeyer HE; Lu L; Cooper S; Ruggieri L; Li ZH; Lyman SD
    Exp Hematol; 1995 Sep; 23(10):1121-9. PubMed ID: 7544740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor.
    Sakabe H; Kimura T; Zeng Z; Minamiguchi H; Tsuda S; Yokota S; Hodohara K; Abe T; Lyman SD; Sonoda Y
    Eur J Haematol; 1998 May; 60(5):297-306. PubMed ID: 9654159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis.
    Jacobsen SE; Jacobsen FW; Fahlman C; Rusten LS
    Stem Cells; 1994; 12 Suppl 1():111-26; discussion 126-8. PubMed ID: 7535144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.